Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitisTakao Takahashi, Narayan Shivapurkar, Erick Riquelme, et al.
Cancer Letters|April 29, 2006
Application of a methylation gene panel by quantitative PCR for lung cancersNarayan Shivapurkar, Victor Stastny, Makoto Suzuki, et al.
Cancer Science|April 25, 2006
Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in JapanKeisuke Aoe, Akio Hiraki, Tomoyuki Murakami, et al.
Lancet (London, England)|March 19, 2002
Presence of simian virus 40 DNA sequences in human lymphomasNarayan Shivapurkar, Kenichi Harada, Jyotsna Reddy, et al.
Cancers|October 13, 2021
Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor MicroenvironmentZoe X Malchiodi, Hong Cao, Martha D Gay, et al.
Cancer Research|June 18, 2002
Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomasShinichi Toyooka, Kiyomi O Toyooka, Kenichi Harada, et al.
International Journal of Cancer|August 19, 2005
Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancersTakao Takahashi, Hisayuki Shigematsu, Narayan Shivapurkar, et al.
Clinical Pharmacology and Therapeutics|September 10, 2022
Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non-alcoholic SteatohepatitisAtoosa Rabiee, Martha D Gay, Narayan Shivapurkar, et al.
International Journal of Cancer|February 9, 2005
Aberrant methylation of Reprimo in human malignanciesTakao Takahashi, Makoto Suzuki, Hisayuki Shigematsu, et al.
Oncogene|December 14, 2004
Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infectionMakoto Suzuki, Shinichi Toyooka, Narayan Shivapurkar, et al.
Pageof 6